MitoSense

MitoSense is developing Mitochondria Organelle Transplantation (MOT), a cell biotherapy to replace mitochondria, for neurodegenerative diseases such as ALS, Parkinson's and Alzheimer's. From company website Source · Oct 12, 2026

Keywords: cell therapy neurodegeneration ALS Parkinson's Alzheimer's